Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):288-95

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

ADVANCES IN RADIONUCLIDE THERAPY  


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):288-95

language: English

Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides

Cremonesi M. 1, Ferrari M. 1, Bodei L. 2, Tosi G. 1, Paganelli G. 2

1 Division of Medical Physics European Institute of Oncology, Milan, Italy
2 Division of Nuclear Medicine European Institute of Oncology, Milan, Italy


FULL TEXT  REPRINTS


This paper reviews the methods for calculating dosimetry both after systemic or locoregional injection of radiolabelled peptides. Radiopharmaceutical characteristics, data processing and dosimetric outcomes are reported. The biological effective dose, based on the linear quadratic model, is finally described.

top of page